Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope

Abstract

In this double-blind randomized trial, pacing therapy did not reduce the risk of recurrent syncope in patients with vasovagal syncope. Because of the weak evidence of efficacy of pacemaker therapy and the risk of complications, pacemaker therapy should not be recommended as first-line therapy for patients with recurrent vasovagal syncope.